|
153 MHRA begins to
consider OTC availability of contraceptive pill Potential
benefits of reclassifying oral contraceptives from prescription-only
to pharmacy medicines were discussed at a Medicines and Healthcare products
Regulatory Agency conference in London this week
PJ 2007;278:153
Full Text
153 Tranexamic acid proposed as next
POM-to-P switch The first steps to making
tranexamic acid available as a pharmacy medicine were taken this week
with the launch of a consultation on its switch from POM to P status
PJ 2007;278:153
Full Text
153 First national board meeting Peter
Jones was elected chairman of the Welsh national board of the Royal Pharmaceutical
Society at its inaugural meeting this week
PJ 2007;278:153
Full Text
153 Lord Fraser of Carmyllie criminal charges
dropped Criminal charges levelled against the chairman
of the Royal Pharmaceutical Society's Statutory Committee, Lord Fraser of Carmyllie,
shortly before Christmas have been dropped
PJ 2007;278:153
Full Text
153 Section 60 Order approved The
Pharmacists and Pharmacy Technicians Order 2007, which modernises pharmacy regulation,
was approved by the House of Commons on 5 February
PJ 2007;278:153
Full Text
154 Contract review starts
to gather evidence Pharmacy organisations have
started to give evidence to the Department of Health's review of the pharmacy
contract
PJ 2007;278:154
Full Text
154 Fraud savings reach £800m Savings for the NHS in England since it started to tackle losses due to fraud seven years ago have reached £811m. This is a 12:1 return on investment in counter-fraud work
PJ 2007;278:154
Full Text
154 Drug trial processes improved The Medicines and Healthcare products Regulatory Agency will seek advice from the Commission on Human Medicines and an Expert Advisory Group before approval of trials for high risk “first time in man” (FTIM) drugs, the MHRA has suggested this week
PJ 2007;278:154
Full Text
154 Repeat dispensing uptake disappointing,
say officials Jeanette Howe and Keith Ridge, senior
pharmacy officials at the Department of Health, have expressed some disappointment
over progress on implementation of the new contract, particularly repeat dispensing.
They were giving evidence at the All-Party Pharmacy Group's seventh session of
its inquiry into the future of pharmacy
PJ 2007;278:154
Full Text
154 MPs to investigate medical records computerisation A
House of Commons inquiry has been launched into the planned electronic patient
record and the use to which it will be put
PJ 2007;278:154
Full Text
154 NICE comes under scrutiny The
House of Commons Health Committee is to conduct an inquiry into the work of the
National Institute for Health and Clinical Excellence
PJ 2007;278:154
Full Text
155 England's chief pharmacist
calls for strong leaders Chief pharmacists in NHS
trusts need to become stronger leaders to ensure that clinical pharmacy continues
to develop, Keith Ridge, chief pharmaceutical officer for England, told attendees
at a conference in London last week
PJ 2007;278:155
Full Text
155 Primary care package should include pharmacy-led
medication review Pharmacist-led medication reviews should be included in a national primary care package designed to reduce emergency admissions, David Colin-Thomé, England's director for primary care, argues in a report published this week
PJ 2007;278:155
Full Text
155 Inclusion of practice-based commissioning
leads on PECs represents a conflict of interest Automatic inclusion of practice-based commissioning (PBC) lead clinicians on primary care trust professional executive committees (PECs) has been challenged by national pharmacy bodies in their responses to “Fit to lead”, the Department of Health's consultation on the future of PECs
PJ 2007;278:155
Full Text
156 Guidance on H5N1 post-exposure
prophylaxis issued Guidance on post-exposure prophylaxis
and treatment for farm workers and others involved in outbreaks of avian influenza
due to H5N1 has been issued by the Health Protection Agency. It follows the discovery
of the H5N1 strain of avian influenza on a poultry farm in North Suffolk last
week
PJ 2007;278:156
Full Text
156 Incentives offered for cost-effective flu
vaccine purchasing by pharmacies in Scotland Community
pharmacists in Scotland are being offered a financial incentive to give the NHS
value for money when purchasing influenza vaccines
PJ 2007;278:156
Full Text
156 Motion on Pfizer put to Scottish Parliament A
motion about Pfizer's planned change to its distribution arrangements has been
lodged this week in the Scottish Parliament
PJ 2007;278:156
Full Text
156 Contract updates circulated in Scotland Community
pharmacists in Scotland will this week receive two updates on their new contract:
one from the Scottish Pharmaceutical General Council and the other an NHS circular
PJ 2007;278:156
Full Text
156 Numark launches new concept pharmacy Numark
has launched a new concept pharmacy
PJ 2007;278:156
Full Text
157 PCT considers major outsourcing Hillingdon
Primary Care Trust is considering outsourcing all its operations except those
involving interactions with the public and patients because it has lost control
of its spending. The commissioning of pharmacy services is included in the proposal
PJ 2007;278:157
Full Text
157 NPA claims to represent all The
National Pharmacy Association believes that all community pharmacies in the UK
are members, now that Whitworths Chemists Ltd has joined the organisation
PJ 2007;278:157
Full Text
157 Writing SOPs for CDs Guidance
on how to produce standard operating procedures for handling Controlled Drugs
has been published by the Department of Health
PJ 2007;278:157
Full Text
157 Stoma consultations extended The
deadlines for Department of Health consultations on reimbursement and remuneration
arrangements for stoma and incontinence appliances have been extended to 2 April
so they can be considered in parallel with a terms of service review
PJ 2007;278:157
Full Text
158 Clomifene better than
metformin for PCOS infertility Clomifene is more
useful than metformin for helping women with polycystic ovary syndrome (PCOS)
achieve pregnancy, report US researchers
PJ 2007;278:158
Full Text
158 Aprotinin during coronary artery bypass
graft surgery has long-term mortality risks Patients
given aprotinin, a serine protease inhibitor, to reduce blood loss during coronary
artery bypass graft (CABG) surgery are at an increased risk of death after five
years' follow-up, a study published this week suggests
PJ 2007;278:158
Full Text
158 Intensive statin therapy reduces mortality
in ACS but not CHD Intensive statin therapy reduces
the risk of mortality more than moderate statin therapy in patients with acute
coronary syndrome (ACS), a recent meta-analysis suggests
PJ 2007;278:158
Full Text
158 US study gives clues to views on advance
supply of EHCWomen with an advance supply of emergency hormonal contraception (EHC) are more likely to use it promptly (odds ratio 2.43, 95 per cent confidence interval 1.24–4.80) and report high convenience (4.25, CI 2.32–7.76) than those provided EHC through a clinic, according to a US study
PJ 2007;278:158
Full Text
159 Medicines uptake increases
but geographical variation still exists Uptake
of medicines has increased across England but the rate of increase varies substantially,
according to a report commissioned by the Ministerial Industry Strategy Group,
an advisory body with members from the Department of Health and the pharmaceutical
industry
PJ 2007;278:159
Full Text
159 IT delays medicines licensing Computer
problems at the Medicines and Healthcare products Regulatory Agency have been
blamed for a growing backlog of applications for marketing authorisations
PJ 2007;278:159
Full Text
159 e-Prescribing specification Nine
months of work with health professionals, professional bodies and NHS trusts
culminated last week in publication of the base-line version of the functional
specification for e-prescribing in NHS hospitals in England
PJ 2007;278:159
Full Text |
The
Pharmaceutical Journal